Friday, November 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Industrial

Thyssenkrupp’s Historic Pivot: Defense Boom and Steel Restructuring Reshape Industrial Giant

Robert Sasse by Robert Sasse
October 6, 2025
in Industrial, IPOs, Turnaround
0
Thyssenkrupp Stock
0
SHARES
30
VIEWS
Share on FacebookShare on Twitter

The historic German industrial conglomerate Thyssenkrupp is navigating its most significant transformation in modern history. This dramatic overhaul presents a tale of two diverging business units: while its naval division TKMS prepares for a multi-billion euro market debut, the company’s traditional steel operations face severe contraction with thousands of job cuts and production capacity reductions. Complicating this balancing act, billionaire investor Daniel Kretinsky has unexpectedly exited the steel joint venture, potentially clearing the path for new partnership opportunities with Indian steel producers.

Naval Division TKMS Sets Course for October IPO

Market attention is focused on October 20, when Thyssenkrupp plans to list its marine systems subsidiary TKMS. Financial experts project a valuation between €2.3 and €2.7 billion for the naval defense unit, representing approximately one-third of the entire corporation’s market capitalization.

The strategic maneuver allows Thyssenkrupp to maintain majority control with a 51% stake while generating substantial proceeds from selling the remaining 49% to public market investors. TKMS has capitalized significantly on Europe’s defense spending surge, with its order backlog expanding dramatically to €18.6 billion over five years—more than triple previous levels.

TKMS Financial Highlights:
– Target operating margin exceeding 7% (compared to 4.3% in 2023/24)
– Projected annual revenue growth of 10%
– Current order backlog: €18.6 billion
– Anticipated IPO valuation reaching €2.7 billion

Steel Division Restructuring Accelerates Amid Investor Exit

As TKMS thrives, Thyssenkrupp’s steel operations face substantial downsizing. Internal restructuring documents outline plans to reduce production capacity from 11.5 million tons to between 8.7 and 9.0 million tons. The consolidation will eliminate 5,000 positions by 2030, with an additional 6,000 jobs slated for transfer or sale to external entities.

In a surprising development, Czech billionaire Daniel Kretinsky’s EP Group has withdrawn from its 20% stake in the steel division, acquired just last year. This reversal terminates negotiations for a proposed 50:50 joint venture, dealing a significant setback to CEO Miguel López Borrego’s strategic plans.

Should investors sell immediately? Or is it worth buying Thyssenkrupp?

Paradoxically, Kretinsky’s departure may create opportunity. Indian steel producer Jindal Steel has emerged as a potential new partner, expressing interest in acquiring a stake in Thyssenkrupp’s steel operations.

Hydrogen Transition Strategy Maintains Forward Momentum

Despite substantial cuts to its conventional steel operations, Thyssenkrupp remains committed to its green transformation strategy. The company plans to commission a direct reduction plant in Duisburg by 2027, initially operating on natural gas before transitioning to green hydrogen.

The initiative has already secured a significant endorsement, with Volkswagen signing a letter of intent to purchase CO₂-reduced “bluemint® Steel” beginning in 2028. This early commitment could encourage other automotive manufacturers to follow suit.

Share Performance Reflects Transformation Optimism

Thyssenkrupp’s equity has responded dramatically to these strategic shifts, skyrocketing 275% over the past twelve months. Shares recently reached a 52-week peak of €12.40, indicating strong market confidence in the corporate overhaul.

Technical indicators suggest the stock may be overbought in the near term, with the Relative Strength Index registering at 17.5. However, traditional valuation metrics may prove less relevant during such a fundamental corporate transformation of historic proportions.

Ad

Thyssenkrupp Stock: Buy or Sell?! New Thyssenkrupp Analysis from November 21 delivers the answer:

The latest Thyssenkrupp figures speak for themselves: Urgent action needed for Thyssenkrupp investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 21.

Thyssenkrupp: Buy or sell? Read more here...

Tags: Thyssenkrupp
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Thermo Fisher Stock
Earnings

Thermo Fisher Shares: A Battle for Momentum

November 21, 2025
MP Materials Stock
Commodities

Strategic Defense Partnership Fuels MP Materials’ Global Expansion

November 21, 2025
Plug Power Stock
Analysis

Plug Power Shares Plummet as Convertible Bond Plan Sparks Investor Exodus

November 21, 2025
Next Post
Nordstrom Stock

Nordstrom's Market Exit Marks New Chapter Under Private Ownership

Consumer Portfolio Services Stock

Subprime Auto Lender CPSS Sees Sharp Single-Day Rally Amid Longer-Term Decline

Plus Therapeutics Stock

Plus Therapeutics Shares Surge on Analyst Upgrade and Insider Buying

Recommended

Okta Stock

Okta’s Pivotal Moment: Can the Identity Leader Regain Its Footing?

20 hours ago
2Seventy Bio Stock

Bristol Myers Squibb Finalizes Acquisition of 2Seventy Bio

3 weeks ago
Technology Quantum computing Stock Exchange

Microchip Technology Achieves ISOSAE 21434 Road Vehicle Cybersecurity Engineering Standard Certification

2 years ago
Automotive Trading online

Concerns Raised Over Integration of Elon Musks Grok AI Chatbot into Tesla Vehicles

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Healwell AI Shares Plunge as Growth Strategy Backfires

Tesla Shares Hit the Brakes as Legal and Market Pressures Mount

Apex Critical Metals: Significant Magnetic Discovery Sparks Investor Interest

Rigetti Shares Plunge Amidst Mounting Concerns

Netflix Shares Tumble Amid Acquisition Speculation

Thermo Fisher Shares: A Battle for Momentum

Trending

Nel ASA Stock
Analysis

Nel ASA Shares Face Critical Juncture as Bearish Signals Mount

by Dieter Jaworski
November 21, 2025
0

The investment case for Norwegian hydrogen specialist Nel ASA is facing severe pressure. As shareholders search in...

Apple Stock

Apple Shares Face Crosscurrents as iPhone Demand Surges

November 21, 2025
IBM Stock

IBM Forges Quantum Networking Alliance to Reshape Computing

November 21, 2025
Healwell AI Stock

Healwell AI Shares Plunge as Growth Strategy Backfires

November 21, 2025
Tesla Stock

Tesla Shares Hit the Brakes as Legal and Market Pressures Mount

November 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA Shares Face Critical Juncture as Bearish Signals Mount
  • Apple Shares Face Crosscurrents as iPhone Demand Surges
  • IBM Forges Quantum Networking Alliance to Reshape Computing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com